![Julie Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Julie Allen is currently the Vice President-Clinical Operations at Lexeo Therapeutics, Inc. Prior to her current position, she worked as the Head-Development Operations at Global Blood Therapeutics, Inc. from 2021 to 2023.
Before that, she held the position of Head-Americas Clinical Operations at EMD Serono, Inc. in 2019.
From 2017 to 2019, she served as the Region Head-Site Monitoring & Management at AbbVie, Inc. Ms. Allen obtained her undergraduate degree from the University of Windsor in 1986.
Former positions of Julie Allen
| Companies | Position | End |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 2025-05-01 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-04-30 |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | 2019-03-31 |
| ABBVIE INC. | Corporate Officer/Principal | 2019-01-31 |
Training of Julie Allen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Windsor
 University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Julie Allen
